NCT05630794 2026-03-18
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
National Cancer Institute (NCI)
Phase 1 Recruiting
National Cancer Institute (NCI)
Rapamycin Holdings Inc.
HonorHealth Research Institute
University of Michigan Rogel Cancer Center
Recursion Pharmaceuticals Inc.
Odense University Hospital
Yonsei University